Join Growin Stock Community!

Balchem corporationBCPC.US Overview

US StockBasic Materials
(No presentation for BCPC)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

BCPC AI Insights

BCPC Overall Performance

BCPC AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

BCPC Recent Performance

-0.18%

Balchem corporation

-0.69%

Avg of Sector

-0.31%

S&P500

BCPC PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

BCPC Key Information

BCPC Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

BCPC Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.

Price of BCPC

BCPC FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

BCPC Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
4.78
PE Ratio (TTM)
39.70
Forward PE
38.37
PS Ratio (TTM)
5.68
PB Ratio
4.50
Price-to-FCF
33.84
METRIC
VALUE
vs. INDUSTRY
Gross Margin
35.74%
Net Margin
14.93%
Revenue Growth (YoY)
8.75%
Profit Growth (YoY)
10.24%
3-Year Revenue Growth
4.27%
3-Year Profit Growth
11.01%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
4.78
PE Ratio (TTM)
39.70
Forward PE
38.37
PS Ratio (TTM)
5.68
PB Ratio
4.50
Price-to-FCF
33.84
Gross Margin
35.74%
Net Margin
14.93%
Revenue Growth (YoY)
8.75%
Profit Growth (YoY)
10.24%
3-Year Revenue Growth
4.27%
3-Year Profit Growth
11.01%

  • When is BCPC's latest earnings report released?

    The most recent financial report for Balchem corporation (BCPC) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating BCPC's short-term business performance and financial health. For the latest updates on BCPC's earnings releases, visit this page regularly.

  • Where does BCPC fall in the P/E River chart?

    According to historical valuation range analysis, Balchem corporation (BCPC)'s current price-to-earnings (P/E) ratio is 35.43, placing it in the Value zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of BCPC?

    According to the latest financial report, Balchem corporation (BCPC) reported an Operating Profit of 52.21M with an Operating Margin of 19.81% this period, representing a growth of 9.89% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is BCPC's revenue growth?

    In the latest financial report, Balchem corporation (BCPC) announced revenue of 263.62M, with a Year-Over-Year growth rate of 9.84%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does BCPC have?

    As of the end of the reporting period, Balchem corporation (BCPC) had total debt of 180.69M, with a debt ratio of 0.11. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does BCPC have?

    At the end of the period, Balchem corporation (BCPC) held Total Cash and Cash Equivalents of 74.57M, accounting for 0.04 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does BCPC go with three margins increasing?

    In the latest report, Balchem corporation (BCPC) achieved the “three margins increasing” benchmark, with a gross margin of 35.6%%, operating margin of 19.81%%, and net margin of 14.9%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess BCPC's profit trajectory and future growth potential.

  • Is BCPC's EPS continuing to grow?

    According to the past four quarterly reports, Balchem corporation (BCPC)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 1.23. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of BCPC?

    Balchem corporation (BCPC)'s Free Cash Flow (FCF) for the period is 51.07M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 28.7% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of BCPC?

    The latest valuation data shows Balchem corporation (BCPC) has a Price-To-Earnings (PE) ratio of 35.43 and a Price/Earnings-To-Growth (PEG) ratio of -13.16. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.